Total Knee Arthroplasty

DALLAS — Data presented at the American Association of Hip and Knee Surgeons Annual Meeting showed use of intraosseous vancomycin infusion may reduce periprosthetic joint infection vs. IV vancomycin in revision total knee arthroplasty.

DALLAS — In this video, Christopher N. Carender, MD, discussed results that showed surgeon volume may not be a modifiable risk factor for revision and periprosthetic joint infection after total knee arthroplasty in patients with obesity.

DALLAS — Glucagon-like peptide-1 receptor agonists may reduce complications after total knee arthroplasty in patients with obesity but who are not diabetic, according to presented results.

DALLAS — Results presented at the American Association of Hip and Knee Surgeons Annual Meeting showed 14 days may be the optimal cutoff time for glucagon-like peptide-1 receptor agonists prior to primary hip or knee arthroplasty.

The American Joint Replacement Registry released its 2024 report on trends in arthroplasty, according to a presenter at the American Association of Hip and Knee Surgeons Annual Meeting.

DALLAS — In this video, Sumon Nandi, MD, MBA, discussed results of a novel total joint arthroplasty discharge protocol that does not require formal physical therapy clearance for same-day discharge.

DALLAS —Patients who did not have patella resurfacing at the time of total knee arthroplasty had increased revision rates, according to data presented at the American Association of Hip and Knee Surgeons Annual Meeting.

DALLAS — While rare, vascular injuries during total knee arthroplasty do occur, with the most common being injury to the popliteal artery, according to a presenter at the American Association of Hip and Knee Surgeons Annual Meeting.

DALLAS —Successful manipulation under anesthesia with or without lysis of adhesion after total knee arthroplasty may provide a gain of 30° of knee flexion, according to data presented here.

PHILADELPHIA — In this video from the American Society of Anesthesiologists Annual Meeting, Alberto E. Ardon, MD, FASA, discusses the impact of modern regional anesthesia techniques in outpatient arthroplasty.